Trial intelligence / Profile preview

Willow bark for primary dysmenorrhea

IRCT20180123038486N1Phase 3Completed

Sponsor
Shahrekord University of Medical Sciences
Start
May 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of white willow bark in primary dysmenorrhea (PD), sponsored by Shahrekord University of Medical Sciences. Started May 2015; status: completed.

02

Drugs

white willow bark
03

Conditions

primary dysmenorrhea (PD)

Beyond the preview

Go deeper on IRCT20180123038486N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20180123038486N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call